Tate Jeffrey's Form 4 filing
Cyclo Therapeutics, Inc. (CYTH) · filed Apr 29, 2022
- Accession no.
- 0001437749-22-010226
- Filed
- Apr 29, 2022
- Trade date
- Apr 28-29, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.28K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tate JeffreyCIK 0001499075 | Director, Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2022 | Common Stock | PPurchaseAcquired | +635 | $2.50 | +$1,587.5 | 27,795 | Direct | |
| Apr 29, 2022 | Common Stock | PPurchaseAcquired | +300 | $2.70 | +$810 | 28,095 | Direct | |
| Apr 29, 2022 | Common Stock | PPurchaseAcquired | +1,065 | $2.71 | +$2,886.15 | 29,160 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.